MDT · News · 20261016N
MiniMed Separation
Medtronic plc · 2026-10-16 · Importance 65 · Surprise 60 · In source text
Medtronic completed the separation of MiniMed through an oversubscribed share exchange, ending Medtronic’s ownership stake in the diabetes technology business. Medtronic shareholders exchanged 55 million Medtronic ordinary shares for 252.8 million newly issued MiniMed common shares. MiniMed became an independent public company and is working to exit technology service agreements with Medtronic, with most expected to be completed by 2027.
Key facts
- Under the exchange, Medtronic's shareholders exchanged 55 million ordinary shares for 252.8 million newly issued MiniMed common shares. source
- Medtronic plc sold all of its remaining shares in MiniMed after an oversubscribed exchange offer, completing the separation. source
- As a result of the exchange offer, Medtronic plc no longer holds an equity stake in MiniMed. source
- Medtronic plc is advancing the MiniMed separation. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | realized | — | Medtronic plc sold all of its remaining shares in MiniMed after an oversubscribed exchange offer, completing the separation. |
| assets | negative | realized | — | Medtronic plc sold all of its remaining shares in MiniMed after an oversubscribed exchange offer, completing the separation. |